Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 July 1999

Effect of application of n-3 polyunsaturated fatty acids on blood serum concentration of von Willebrand factor in type II diabetes mellitus

Peter Hab‡an, Robert Simoncic, Jana Klvanova, Eva Zidekova

Med Sci Monit 1999; 5(4): CR661-665 :: ID: 503471

Abstract

Increased concentration of von Willebrand factor (vWF) is generally accepted as independent risk factor for cardiovascular complications in type 2 diabetes. In attempt to decrease its blood serum concentration, 34 patients with type 2 diabetes mellitus were supplemented for 28 days with 1.7 g of eicosapentaenoic acid (EPA) plus 1.15 g docosahexaenoic acid (DHA)per each day, followed by a 3 months' wash-out control period with20 patients. After the period of supplementation with EPA and DHA, there was a significant decline in vWF by 15.66 % of ref. plasma (95% CI 6.13, 25.19) followed by its significant increase during the wash-out (on average by 19.15 %; 95% CI 1.24, 37.06). Changes in vWF (DvWF) after intervention correlated with vWF baseline values (r=Ð0.415; p=0.015) and during the entire follow-up (intervention + wash-out) also inversely with changes in EPA, DHA and 22: 5n3 (docosapentaenoic acid) in serum phospholipids (r=Ð0.409, r=-0.454, r=-0.418; p=0.002, p=0.0006, p=0.002, respectively). Supplementation with long-chain n-3 PUFAs (incl. EPA and DHA) in this indication seems to be beneficial also because of its other effects, e. g. on lipoprotein and eicosanoid spectrum, blood rheology etc.

Keywords: n-3 fatty acids, von Willebrand Factor, type 2 diabetes

0 Comments

Editorial

01 January 2023 : Editorial  

Editorial: Current Status of Two Adjuvanted Malaria Vaccines and the World Health Organization (WHO) Strategy to Eradicate Malaria by 2030

Dinah V. Parums
Science Editor, Medical Science Monitor, International Scientific Information, Inc., Melville, NY, USA

DOI: 10.12659/MSM.939357

Med Sci Monit 2023; 29:e939357

SARS-CoV-2/COVID-19

26 January 2023 : Editorial  

Editorial: The XBB.1.5 (‘Kraken’) Subvariant of Omicron SARS-CoV-2 and its Rapid Global Spread

Med Sci Monit In Press; DOI: 10.12659/MSM.939580  

19 January 2023 : Clinical Research  

Evaluation of Health-Related Quality of Life and Mental Health in 729 Medical Students in Indonesia During ...

Med Sci Monit In Press; DOI: 10.12659/MSM.938892  

27 December 2022 : Clinical Research  

Effect of Physiotherapy to Correct Rounded Shoulder Posture in 30 Patients During the COVID-19 Pandemic in ...

Med Sci Monit 2022; 28:e938926

In Press

30 Jan 2023 : Clinical Research  

Splenic Artery Steal Syndrome in Patients with Liver Cirrhosis: A Retrospective Clinical Study

Med Sci Monit In Press; DOI: 10.12659/MSM.938998  

27 Jan 2023 : Database Analysis  

Association Between Neutrophil-Lymphocyte Ratio and All-Cause Mortality in Critically Ill Patients with Chr...

Med Sci Monit In Press; DOI: 10.12659/MSM.938554  

27 Jan 2023 : Clinical Research  

Proposal for a Simple Equation for Limb Muscle Weight Calculation

Med Sci Monit In Press; DOI: 10.12659/MSM.938606  

26 Jan 2023 : Editorial  

Editorial: The XBB.1.5 (‘Kraken’) Subvariant of Omicron SARS-CoV-2 and its Rapid Global Spread

Med Sci Monit In Press; DOI: 10.12659/MSM.939580  

Most Viewed Current Articles

13 Nov 2021 : Clinical Research  

Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...

DOI :10.12659/MSM.932788

Med Sci Monit 2021; 27:e932788

30 Dec 2021 : Clinical Research  

Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...

DOI :10.12659/MSM.935379

Med Sci Monit 2021; 27:e935379

08 Mar 2022 : Review article  

A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...

DOI :10.12659/MSM.936292

Med Sci Monit 2022; 28:e936292

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750